36.1% of patients on new Wegovy (NOVOB DC) weight-loss pill have no prior experience on a GLP-1 drug, new study finds; Among patients on new Wegovy pill, 21.1% switched from injectable wegovy, 15.8% switched from injectable zepbound
Newsquawk Staff ·
36.1% of patients on new Wegovy (NOVOB DC) weight-loss pill have no prior experience on a GLP-1 drug, new study finds; Among patients on new Wegovy pill, 21.1% switched from injectable wegovy, 15.8% switched from injectable zepbound.
What it means
The new study revealing that 36.1% of patients using Wegovy have no prior experience with GLP-1 drugs highlights a significant potential for market expansion beyond existing users. This finding could bolster Novo Nordisk's market position and may drive increased interest in their product line, impacting competitor dynamics in the weight-loss pharmaceuticals sector.
- Novo Nordisk (NOVOB DC) to present new liver data across Wegovy 2.4mg and investigational efruxifermin at The Liver Meeting 2026
- Stellantis (STLAM IM) earnings call summary: Co. firmly believes will beat initial goal of EUR 2.4bln cost savings in 2027
- Mercedes-Benz Group (MBG GY) CEO says the Co. is preparing a broader strategy update covering 2030 and beyond, with China remaining a core pillar of its long-term plans
- Epiroc (EPIA SS) Q3 2026 (SEK): Revenue 16.8bln (exp. 17.4bln), Orders 17.5bln (exp. 17.8bln), Adj. EBIT 3.43bln (exp. 3.49bln)
- Orion (ORNBV FH) Q3 2026 (EUR): Sales 542.2mln (exp. 546.7mln). Raises its FY26 Net sales guidance to 2.07-2.14bln (prev. guided 2-2.1bln)
Related headlines
- EUROPEAN MOVERS: Standard Chartered (STAN LN) +4.5%, Deutsche Bank (DBK GY) +3.3%, BASF (BAS GY) +0.9%, Danone (BN FP) +0.9%, BNP Paribas (BNP FP) U/C, Santander (SAN SM) -3.2%, GSK (GSK LN) -4.8%7 hours ago
- EUROPEAN OPEN: SKHY surges after Q3 profits; EQNR NO lifts FY production view; UBSG SW Q3 net income miss; DBK GY posts third straight record profit; MBG GY Q3 revenue & earnings fall; ULVR LN raises FY volume growth view; GSK LN Q3 profit & revenue beat7 hours ago
- Newsquawk Daily European Equity Opening News - 28th October 20268 hours ago
- Intesa Sanpaolo (ISP IM) receives ECB approval for its Monte dei Paschi (BMPS IM) bid 19 hours ago
- Saint Gobain (SGO FP) Q3 2026 (EUR): Sales 11.6bln (exp. 11.6bln)22 hours ago
- ASM International NV (ASM NA) Q3 2026 (EUR): Adj. net income 315.4mln, Revenue 1.16bln (exp. 1.11bln)22 hours ago
- Eni (ENI IM) CEO says it is too early to seek additional partners for Venezuela's Perla gas field1 day ago
- Nokian Tyres (TYRES FH) Q3 2026 (EUR): Sales 359.1mln (exp. 374.8mln), Segment EBIT 47mln (exp. 41.7mln)1 day ago
- Mercedes-Benz Group (MBG GY) lowers FY26 Mercedes-Benz Cars adj. return on sales guidance to 2-3% (prev. guided 3-5%) and now expects Group EBIT to be flat Y/Y (prev. guided significantly higher Y/Y)1 day ago
- EUROPEAN OPEN: HSBA LN Q3 pretax profit misses, announces USD 1bln buyback; AMAT raises BESI NA stake; NOVN SW raises FY26 core earnings outlook; ORA FP raises FY26 EBITDAaL outlook; UMG NA held prelim take-private talks; RKT LN cuts FY26 core LFL growth 1 day ago
- European Movers: BE Semi (BESI NA) +9.4%, Porsche AG (P911 GY) +3.2%, Novartis (NOVN SW) +3.1%, Vistry (VTY LN) +2.9%, UMG (UMG NA) +2.9%, HSBC (HSBA LN) -7.0%1 day ago
- Additional European Equity News - 27th October 20261 day ago
- European pre-market summary - 27th October 2026: Futures falter as energy lifts and heavyweights dissapoint1 day ago
- Newsquawk Daily European Equity Opening News - 27th October 20261 day ago
- [MARKET UPDATE] Gradual pressure in the crude complex helps lift sentiment across European and US equity futures; a move which lacks a clear driver, but with markets potentially focusing on a delegation meeting in Tehran on Monday2 days ago